Clinical Trials Logo

Motivational Interviewing clinical trials

View clinical trials related to Motivational Interviewing.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06156631 Not yet recruiting - Hypertension Clinical Trials

Uncontrolled Hypertension Management Among Jordanian Adults

DASH-ExMAMI
Start date: June 1, 2024
Phase: N/A
Study type: Interventional

This study will evaluate a newly developed multimodal health intervention including dietary approach to stop hypertension (DASH) diet, exercise (Ex), and medication adherence (MA) using motivational interviewing (MI) counselling (DASH-Ex MAMI) for hypertensive Jordanian adults in primary care settings.

NCT ID: NCT05767190 Not yet recruiting - Clinical trials for Sleep Apnea, Obstructive

The MotivAir Study to Improve CPAP Adherence in OSAS Patients

MotivAir
Start date: March 2023
Phase: N/A
Study type: Interventional

This study aims to evaluate the effectiveness of the MotivAir program an intervention based on Motivational Interviewing (MI) principles and techniques - in enhancing adherence to Continuous Positive Airway Pressure (CPAP) therapy among patients with Obstructive Sleep Apnea Syndrome (OSAS). Methods. A multicenter randomized controlled trial (RCT) design with random allocation at the level of the individual will be conducted to compare the impact of the experimental program (usual care plus MI) with a control group receiving usual care only in improving selected clinical and psychological parameters in the patients. A minimum sample of 80 participants (40 patients per group) will be recruited in each center according to the inclusion criteria. After the initial screening, participants will be randomly assigned to either the experimental group or the control condition. The program will last 180 days and will be delivered by a trained nurse. The impact of the MotivAir program on selected primary (adherence to CPAP in terms of average hours of usage per night and the Apnea-Hypopnea Index, AHI) and secondary (motivation, perceived competence, quality of life, sleepiness, as well as the emotional state, daily life activities, and quality of the social relationships of the person) outcomes will be measured at baseline, and after 1-, 3-, and 6-month from CPAP initiation